Displaying 1 - 50 of 2204 results
Released Company Title Industry Topic
18 Apr 2024
20:38 CEST
AMUNDI 2023 Universal Registration Document available 30202010 Asset Managers and Custodians Corporate life
18 Apr 2024
20:38 CEST
AMUNDI Mise à disposition du Document d’Enregistrement Universel 2023 30202010 Asset Managers and Custodians Corporate life
18 Apr 2024
20:02 CEST
MANITOU BF Availability of the 2023 Universal Registration Document (URD) 50204020 Machinery: Construction and Handling Income
18 Apr 2024
20:02 CEST
MANITOU BF Mise à disposition du Document d’Enregistrement Universel 2023 50204020 Machinery: Construction and Handling Income
18 Apr 2024
19:29 CEST
ECOSLOPS Ecoslops : Résultats annuels 2023 60101030 Oil Equipment and Services -
18 Apr 2024
19:29 CEST
ECOSLOPS Ecoslops : 2023 annual results 60101030 Oil Equipment and Services -
18 Apr 2024
19:03 CEST
DANONE DANONE : Informations relatives au nombre total de droits de vote et d’actions 45102020 Food Products Other subject
18 Apr 2024
19:03 CEST
DANONE Danone: Information on the total number of voting rights and shares 45102020 Food Products Other subject
18 Apr 2024
19:00 CEST
DEKUPLE DÉKUPLE: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023 40301020 Media Agencies Income
18 Apr 2024
19:00 CEST
VIEL ET COMPAGNIE VIEL & Cie : Réduction de capital par annulation d’actions 30202015 Investment Services Other financial transaction
18 Apr 2024
18:17 CEST
SMTPC SMTPC_Mise à disposition du Rapport annuel 2023 50206060 Transportation Services Legal
18 Apr 2024
18:15 CEST
GROUPE SFPI SFPI GROUP: publication des résultats 2023 40301030 Publishing General meeting / Board Meeting
18 Apr 2024
18:15 CEST
GROUPE SFPI SFPI GROUP: publication of 2023 annual results 40301030 Publishing General meeting / Board Meeting
18 Apr 2024
18:11 CEST
PHOTONIKE CAPITAL Nucleus Life AG approval of Financial Statements 2023 next April, 29th. Net Profit at 596.897 CHF 30202010 Asset Managers and Custodians Commercial results
18 Apr 2024
18:00 CEST
ONCODESIGN PRECISION MEDICINE Degroof Petercam Initiates Coverage of Oncodesign Precision Medicine 20103010 Biotechnology Other subject
18 Apr 2024
18:00 CEST
THERANEXUS Theranexus and BBDF announce final and positive safety and efficacy data in the Phase I/II trial testing Batten-1 20103010 Biotechnology Legal
18 Apr 2024
18:00 CEST
L'OREAL Chiffre d’affaires du 1er trimestre 2024 40204035 Cosmetics Sales
18 Apr 2024
18:00 CEST
KERLINK KERLINK : Résultats annuels 2023. Confiance dans les perspectives d’activité 2024. 15101010 Telecommunications Equipment General meeting / Board Meeting
18 Apr 2024
18:00 CEST
NEOLIFE Changement de gouvernance à la tête du Conseil de surveillance de NEOLIFE 50101035 Building Materials: Other -
18 Apr 2024
18:00 CEST
PRODWAYS GROUP Activité de 1er trimestre 2024 : 16 M EUR de revenus 50204050 Machinery: Specialty Sales, Income
18 Apr 2024
18:00 CEST
ONCODESIGN PRECISION MEDICINE Degroof Petercam initie la couverture d’Oncodesign Precision Medicine 20103010 Biotechnology Other subject
18 Apr 2024
18:00 CEST
ESSILORLUXOTTICA EssilorLuxottica: Chiffre d'affaires T1 2024 - Trajectoire solide du chiffre d’affaires au premier trimestre 20102015 Medical Supplies Commercial results
18 Apr 2024
18:00 CEST
AELIS FARMA Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder 20103010 Biotechnology Other subject
18 Apr 2024
18:00 CEST
INTEGRAGEN IntegraGen : Résultats annuels 2023 – Excédent brut d’exploitation positif reflétant la bonne maîtrise des coûts 20103010 Biotechnology Income
18 Apr 2024
18:00 CEST
INTEGRAGEN IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control 20103010 Biotechnology Income
18 Apr 2024
18:00 CEST
AMPLITUDE SURGICAL Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates 20102010 Medical Equipment Sales
18 Apr 2024
18:00 CEST
THERANEXUS Theranexus et BBDF annoncent les données finales et positives de sécurité et d'efficacité de Batten-1 dans l'étude de phase 1/2 20103010 Biotechnology Legal
18 Apr 2024
18:00 CEST
L'OREAL First quarter 2024 sales 40204035 Cosmetics Sales
18 Apr 2024
18:00 CEST
PRODWAYS GROUP Activity of the 1st quarter 2024: EUR 16 M in revenue 50204050 Machinery: Specialty Sales, Income
18 Apr 2024
18:00 CEST
KERLINK KERLINK : 2023 full-year results. Confident business outlook for 2024. 15101010 Telecommunications Equipment General meeting / Board Meeting
18 Apr 2024
18:00 CEST
ESSILORLUXOTTICA EssilorLuxottica: Fatturato del primo trimestre 2024 - Solida traiettoria di crescita del fatturato nel primo trimestre 20102015 Medical Supplies Commercial results
18 Apr 2024
18:00 CEST
OBIZ S.A. Le groupe Obiz(C) conclut un protocole d'accord en vue de l'acquisition de HA PLUS PME, plateforme d'achats qui permet aux entreprises de réaliser des économies 10101020 Consumer Digital Services Legal
18 Apr 2024
18:00 CEST
AMPLITUDE SURGICAL Amplitude Surgical - Chiffre d’affaires consolidé 9 mois de l’exercice 2023-24 de 79,6 M€, en progression de +6,1% à taux constants 20102010 Medical Equipment Sales
18 Apr 2024
18:00 CEST
ESSILORLUXOTTICA EssilorLuxottica: Q1 2024 Revenue - Solid revenue trend in the first quarter 20102015 Medical Supplies Commercial results
18 Apr 2024
18:00 CEST
AELIS FARMA Aelis Farma annonce la dernière visite du dernier patient (Last Patient Last Visit ou LPLV) de l’étude de phase 2b avec AEF0117 dans le traitement de l’addiction au cannabis 20103010 Biotechnology Other subject
18 Apr 2024
17:52 CEST
DIAGNOSTIC MEDICAL SYSTEMS Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024 20102010 Medical Equipment Commercial results
18 Apr 2024
17:47 CEST
PULLUP ENTERTAINMENT FOCUS ENTERTAINMENT: PULLUP ENTERTAINMENT ANNONCE UN CHIFFRE D'AFFAIRES AU QUATRIEME TRIMESTRE EN CROISSANCE DE +12% A 59 M€ 40203040 Electronic Entertainment Sales, Other subject
18 Apr 2024
17:47 CEST
PULLUP ENTERTAINMENT FOCUS ENTERTAINMENT: PULLUP ENTERTAINMENT ANNOUNCES FOURTH-QUARTER REVENUE GROWTH OF +12% TO €59M   40203040 Electronic Entertainment Sales, Other subject
18 Apr 2024
17:45 CEST
IPSOS Ipsos : Poursuite de la dynamique de croissance au 1er trimestre 40301020 Media Agencies Income
18 Apr 2024
17:45 CEST
IPSOS Ipsos: Continued momentum in Q1 40301020 Media Agencies Income
18 Apr 2024
17:45 CEST
PULLUP ENTERTAINMENT FOCUS ENTERTAINMENT: NOMINATION D’AHMED BOUKHELIFA DIRECTEUR GÉNÉRAL DÉLÉGUE CHARGÉ DES STUDIOS 40203040 Electronic Entertainment Other subject
18 Apr 2024
17:45 CEST
PULLUP ENTERTAINMENT FOCUS ENTERTAINMENT: AHMED BOUKHELIFA APPOINTED DEPUTY CHIEF EXECUTIVE OFFICER OF PULLUP ENTERTAINMENT, IN CHARGE OF THE STUDIOS 40203040 Electronic Entertainment Other subject
18 Apr 2024
17:45 CEST
CLASQUIN CLASQUIN : MISE A DISPOSITION  DU RAPPORT ANNUEL 2023 50206040 Delivery Services Legal
18 Apr 2024
17:45 CEST
ARGAN ARGAN : Paiement du dividende en actions - 28 % de l’actionnariat y souscrit en 2024 35102030 Office REITs Change in Capital
18 Apr 2024
17:45 CEST
DAMARTEX DAMARTEX / Chiffre d’affaires des neuf premiers mois de l’exercice 2023/2024 40401020 Apparel Retailers Share history
18 Apr 2024
17:45 CEST
ORAPI Correction: ORAPI : Mise à disposition du Rapport Financier Annuel 2023 55201000 Chemicals: Diversified Other subject
18 Apr 2024
17:45 CEST
ARGAN ARGAN: Scrip dividend - Subscribed by 28% of the shareholding in 2024 35102030 Office REITs Change in Capital
18 Apr 2024
17:43 CEST
SPIE Communiqué de presse - SPIE - Finalisation de l’acquisition de ICG Group en Allemagne 50101015 Engineering and Contracting Services Mergers, Acquiqitions, Transferts
18 Apr 2024
17:43 CEST
SPIE Press release - SPIE - Closing of the acquisition of ICG Group in Germany 50101015 Engineering and Contracting Services Mergers, Acquiqitions, Transferts
18 Apr 2024
17:40 CEST
MERCIALYS Mercialys: 2024 First-quarter Activity 35102045 Retail REITs Other subject